P 434 (Naproxen 220 mg)
Pill imprint P 434 has been identified as Naproxen sodium 220 mg.
Naproxen is used in the treatment of back pain; osteoarthritis; ankylosing spondylitis; pain; sciatica (and more), and belongs to the drug class nonsteroidal anti-inflammatory agents. Risk cannot be ruled out during pregnancy. Naproxen 220 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for P 434 (Naproxen 220 mg)
- 220 mg
- 10.00 mm
- Rx and/or OTC
- Drug Class:
- Nonsteroidal anti-inflammatory agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
|NDC Code||Manufacturer / Repackager|
|63868-0465||Chain Drug Marketing Association|
|23490-6709||Palmetto State Pharmaceuticals Inc (repackager)|
Note: Inactive ingredients may vary.
Naproxen sodium is associated with the treatment of:
- Ankylosing Spondylitis
- Aseptic Necrosis
- Back Pain
- Chronic Myofascial Pain
- Diffuse Idiopathic Skeletal Hyperostosis
- Frozen Shoulder
- Gout, Acute
- Juvenile Rheumatoid Arthritis
- Muscle Pain
- Period Pain
- Rheumatoid Arthritis
- Transverse Myelitis
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...